Test Price
2,800 AED✅ Home Collection Available
FGFR2 Gene Bent Bone Dysplasia Syndrome Genetic Test – DHA-Approved NGS Analysis (2800 AED)
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited NGS methodology.
- Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection (available daily 8 AM – 11 PM).
- Clinical Guidance: Immediate telephonic post-test clinical correlation and genetic counselling included.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
- Price: 2,800 AED inclusive of genetic counselling and digital report.
- Turnaround Time: 3 – 4 weeks from sample receipt.
Test Overview & Methodology
This advanced molecular test uses Next‑Generation Sequencing (NGS) to analyse the entire coding region of the FGFR2 gene, delivering a definitive diagnosis of Bent Bone Dysplasia Syndrome with exceptional depth and clinical utility. The Illumina‑based platform achieves 1000x read depth with orthogonal confirmatory testing to guarantee variant accuracy.
| Feature | Our FGFR2 NGS Test | Closest Alternative (Single‑Gene Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% analytical sensitivity; covers all FGFR2 exons and splice sites | Targets only known hotspots; may miss rare or novel variants |
| Methodology | Illumina‑based NGS with 1000x read depth and orthogonal confirmatory testing | Capillary electrophoresis (Sanger), lower throughput and no copy‑number detection |
| Turnaround Time | 3 – 4 Weeks with online digital report | 4 – 6 Weeks, paper report only |
| Regulatory Compliance | DHA‑approved, ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), UAE PDPL | Basic DHA licensing, no advanced accreditation |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403), emphasizes: “I understand that pursuing a genetic diagnosis for Bent Bone Dysplasia Syndrome can feel overwhelming. This NGS test offers a conclusive molecular answer that, when integrated with a thorough clinical evaluation and genetic counselling, empowers families to navigate treatment, surgical planning, and reproductive options with confidence. Please remember that a genetic result is one piece of a larger clinical picture and must always be correlated with physical findings by your specialist.”
⚠ Important Medication Advisory
Do not discontinue or adjust any prescribed medication (e.g., analgesics, hormone therapies, calcium/vitamin D supplements) without consulting your treating physician. This genetic test does not replace ongoing clinical management or current treatments.
🚨 Exclusion Criteria & Emergency Red Flags
- Known non‑FGFR2 skeletal dysplasia diagnosed via alternative confirmed genetic testing.
- Active hematologic malignancy or recent bone marrow transplant that may compromise DNA quality (requires physician clearance).
- Minor patients (below 18 years) must be accompanied by a legal guardian; testing without valid consent under UAE Federal Law No. 3 of 2016 (Wadeema's Law) is strictly prohibited.
- If you experience new‑onset pathological fractures, rapidly worsening limb deformity with neurovascular compromise (numbness, pallor, paralysis), or signs of raised intracranial pressure (severe headache, vomiting, downward gaze), seek emergency medical care immediately. This test is for elective genetic diagnosis, not acute crisis management.
Patient FAQ & Clinical Guidance
1. What exactly does the FGFR2 Bent Bone Dysplasia NGS test detect?
Our FGFR2 NGS test identifies pathogenic single‑nucleotide variants, small insertions/deletions, and copy‑number changes across all coding exons and splice junctions of the FGFR2 gene with >99.9% analytical sensitivity and specificity. This provides a definitive molecular diagnosis for Bent Bone Dysplasia Syndrome.
2. Is this test safe and legally approved for children and minors in the UAE?
Yes, the test is permitted for minors when ordered by a UAE‑licensed paediatric geneticist or craniofacial surgeon and accompanied by legal guardian consent, in full compliance with Wadeema’s Law (Federal Law No. 3 of 2016) and DHA guidelines for minor genetics. Parental or guardian consent is mandatory.
3. How will I receive my results and what support is available afterward?
You receive an encrypted digital report within 3–4 weeks, followed by a dedicated telephonic consultation with a clinical genetic counsellor who explains the findings, implications for family members, and next steps in management. The service includes post-test counselling at no extra cost.
4. Is home sample collection available for this genetic test?
Yes, our VIP mobile phlebotomy service is available daily from 8 AM to 11 PM. A licensed nurse visits your home to collect a peripheral blood sample under strict cold‑chain conditions. Alternatively, you may visit our DHCC facility for sample submission.
UAE Regulatory & Data Privacy Adherence
This laboratory strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for genetic data privacy, Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. All reports are reviewed by a DHA‑certified molecular pathologist. Your genetic information is encrypted, stored securely, and never shared without your explicit consent.
Clinical & Logistical Metadata
| Test Name | FGFR2 Gene Bent Bone Dysplasia Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube). VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina platform, 1000x read depth with confirmatory Sanger sequencing for positive findings. |
| ICD-10-CM Code | Q78.8 (Other specified osteochondrodysplasias) |
| LOINC Code | 93296-0 (FGFR2 gene targeted mutation analysis in blood or tissue by NGS) |
| DHA Facility License No. & Address | DHA License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab: DNA Labs UAE. |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians